{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:56:47Z","timestamp":1792439807730,"version":"4.5.0"},"reference-count":125,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2017.00139","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T08:04:52Z","timestamp":1505808292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":122,"title":["Interleukin-13 in Asthma and Other Eosinophilic Disorders"],"prefix":"10.3389","volume":"4","author":[{"given":"Emma","family":"Doran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile T. J.","family":"Holweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Brumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Arron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00441-010-1049-6","article-title":"Eosinophils in innate immunity: an evolving story","volume":"343","author":"Shamri","year":"2011","journal-title":"Cell Tissue Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12016-015-8525-4","article-title":"The eosinophil in infection","volume":"50","author":"Ravin","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nri2199","article-title":"Protective immune mechanisms in helminth infection","volume":"7","author":"Anthony","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1182\/blood-2012-06-330845","article-title":"The expanding role(s) of eosinophils in health and disease","volume":"120","author":"Jacobsen","year":"2012","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/thx.8.3.207","article-title":"A clinical and pathological study of fatal cases of status asthmaticus","volume":"8","author":"Houston","year":"1953","journal-title":"Thorax"},{"key":"B8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4049\/jimmunol.147.1.254","article-title":"Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor","volume":"147","author":"Lamas","year":"1991","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0091-6749(97)70237-9","article-title":"Human eosinophils","volume":"100","author":"Weller","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/362248a0","article-title":"Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses","volume":"362","author":"Minty","year":"1993","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1172\/JCI5909","article-title":"Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production","volume":"103","author":"Zhu","year":"1999","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1126\/science.282.5397.2258","article-title":"Interleukin-13: central mediator of allergic asthma","volume":"282","author":"Wills-Karp","year":"1998","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.immunol.23.021704.115821","article-title":"Regulation of Th2 differentiation and Il4 locus accessibility","volume":"24","author":"Ansel","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri2735","article-title":"How are T(H)2-type immune responses initiated and amplified?","volume":"10","author":"Paul","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bcp.2008.04.002","article-title":"IL-13 as a therapeutic target for respiratory disease","volume":"76","author":"Kasaian","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4049\/jimmunol.1301761","article-title":"Endogenously expressed IL-13R\u00ce\u00b12 attenuates IL-13-mediated responses but does not activate signaling in human lung fibroblasts","volume":"193","author":"Chandriani","year":"2014","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jaci.2014.05.019","article-title":"TNF-\u03b1\/IL-17 synergy inhibits IL-13 bioactivity via IL-13R\u00ce\u00b12 induction","volume":"134","author":"Badalyan","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6067","DOI":"10.1073\/pnas.1220572110","article-title":"Eosinophil adoptive transfer system to directly evaluate pulmonary eosinophil trafficking in vivo","volume":"110","author":"Wen","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1165\/rcmb.2012-0150OC","article-title":"\u03b1(M)\u03b2(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin","volume":"48","author":"Johansson","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1084\/jem.181.3.1211","article-title":"Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung","volume":"181","author":"Rothenberg","year":"1995","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1067\/mai.2001.118600","article-title":"IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism","volume":"108","author":"Pope","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"16418","DOI":"10.1073\/pnas.0607863103","article-title":"A central regulatory role for eosinophils and the eotaxin\/CCR3 axis in chronic experimental allergic airway inflammation","volume":"103","author":"Fulkerson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1084\/jem.20020656","article-title":"Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo","volume":"195","author":"Yu","year":"2002","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1126\/science.1100283","article-title":"A critical role for eosinophils in allergic airways remodeling","volume":"305","author":"Humbles","year":"2004","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1126\/science.1099472","article-title":"Defining a link with asthma in mice congenitally deficient in eosinophils","volume":"305","author":"Lee","year":"2004","journal-title":"Science"},{"key":"B27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jaci.2013.03.024","article-title":"Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK\/ERK activation","volume":"132","author":"Kano","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jaip.2015.01.013","article-title":"Biologic therapies targeting eosinophils: current status and future prospects","volume":"3","author":"Legrand","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/ACI.0000000000000346","article-title":"Asthma guidelines: the global initiative for asthma in relation to national guidelines","volume":"17","author":"Becker","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","article-title":"Asthma: defining of the persistent adult phenotypes","volume":"368","author":"Wenzel","year":"2006","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1600-065X.2011.01032.x","article-title":"Human asthma phenotypes: from the clinic, to cytokines, and back again","volume":"242","author":"Bhakta","year":"2011","journal-title":"Immunol Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.jaci.2011.12.979","article-title":"Asthma outcomes: biomarkers","volume":"129","author":"Szefler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/ers.12.81","article-title":"Eosinophils as diagnostic tools in chronic lung disease","volume":"7","author":"Eltboli","year":"2013","journal-title":"Expert Rev Respir Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1056\/NEJM197505292922204","article-title":"Total eosinophil counts in the management of bronchial asthma","volume":"292","author":"Horn","year":"1975","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/thx.42.6.452","article-title":"Peripheral blood eosinophil counts and bronchial responsiveness","volume":"42","author":"Taylor","year":"1987","journal-title":"Thorax"},{"key":"B38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1398-9995.1991.tb00583.x","article-title":"Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients","volume":"46","author":"Griffin","year":"1991","journal-title":"Allergy"},{"key":"B39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1164\/ajrccm.149.3.8118634","article-title":"Relationship of plasma epinephrine and circulating eosinophils to nocturnal asthma","volume":"149","author":"Bates","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1365-2222.1995.tb00024.x","article-title":"Peripheral eosinophil counts as a marker of disease activity in intrinsic and extrinsic asthma","volume":"25","author":"Ulrik","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"B41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3109\/02770909909087292","article-title":"The effect of corticosteroid therapy on blood eosinophils and eosinophilic cationic protein in patients with acute and chronic asthma","volume":"36","author":"Marouf","year":"1999","journal-title":"J Asthma"},{"key":"B42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1378\/chest.119.1.105","article-title":"The relation between peripheral blood leukocyte counts and respiratory symptoms, atopy, lung function, and airway responsiveness in adults","volume":"119","author":"Lewis","year":"2001","journal-title":"Chest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.anai.2014.04.011","article-title":"High blood eosinophil count is associated with more frequent asthma attacks in asthma patients","volume":"113","author":"Tran","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jaci.2012.06.025","article-title":"Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients","volume":"130","author":"Jia","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/cea.12345","article-title":"Full blood count parameters for the detection of asthma inflammatory phenotypes","volume":"44","author":"Zhang","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"key":"B48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S2213-2600(15)00197-6","article-title":"Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial","volume":"3","author":"Brightling","year":"2015","journal-title":"Lancet Respir Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1513\/AnnalsATS.201303-047AW","article-title":"Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthma","volume":"10","author":"Arron","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"B52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2169\/internalmedicine.36.179","article-title":"Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis","volume":"36","author":"Horie","year":"1997","journal-title":"Intern Med"},{"key":"B53","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.157.4.1678","article-title":"Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability","volume":"157","author":"Luttmann","year":"1996","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4049\/jimmunol.154.2.799","article-title":"IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells","volume":"154","author":"Bochner","year":"1995","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1136\/thx.2005.052399","article-title":"Evaluation of airway inflammation by quantitative Th1\/Th2 cytokine mRNA measurement in sputum of asthma patients","volume":"61","author":"Truyen","year":"2006","journal-title":"Thorax"},{"key":"B56","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jaci.2004.08.032","article-title":"Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis","volume":"114","author":"Berry","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4155\/bio.15.254","article-title":"Bioanalytical challenges and improved detection of circulating levels of IL-13","volume":"8","author":"Cai","year":"2016","journal-title":"Bioanalysis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3389\/fimmu.2014.00570","article-title":"Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity","volume":"5","author":"Davoine","year":"2014","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2307\/3282130","article-title":"Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis","volume":"73","author":"Hamann","year":"1987","journal-title":"J Parasitol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/cea.12255","article-title":"Primary lysis of eosinophils in severe desquamative asthma","volume":"44","author":"Persson","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2222.1994.tb00910.x","article-title":"Vesicular transport of peroxidase in human eosinophilic myelocytes","volume":"24","author":"Dvorak","year":"1994","journal-title":"Clin Exp Allergy"},{"key":"B63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jaci.2010.03.026","article-title":"Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma","volume":"126","author":"Kulkarni","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nm.1855","article-title":"Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense","volume":"14","author":"Yousefi","year":"2008","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","article-title":"Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans","volume":"121","author":"Ueki","year":"2013","journal-title":"Blood"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/j.1365-2222.2005.02335.x","article-title":"Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation","volume":"35","author":"Malm-Erjef\u00e4lt","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"B67","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1165\/ajrcmb.23.4.4025","article-title":"Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season","volume":"23","author":"Karawajczyk","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/all.12176","article-title":"Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children","volume":"68","author":"Muniz-Junqueira","year":"2013","journal-title":"Allergy"},{"key":"B69","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1398-9995.2008.01869.x","article-title":"Serum eosinophil granule proteins predict asthma risk in allergic rhinitis","volume":"64","author":"Nielsen","year":"2009","journal-title":"Allergy"},{"key":"B70","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","article-title":"Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials","volume":"4","author":"Hanania","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1183\/09031936.00223411","article-title":"A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma","volume":"41","author":"Piper","year":"2013","journal-title":"Eur Respir J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting \u03b22 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/psp4.12129","article-title":"A mathematical modeling approach to understanding the effect of anti-interleukin therapy on eosinophils","volume":"5","author":"Karelina","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil\u2019s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.aller.2012.03.001","article-title":"The international study of asthma and allergies in childhood (ISAAC) phase three: a global synthesis","volume":"41","author":"Mallol","year":"2013","journal-title":"Allergol Immunopathol"},{"key":"B77","first-page":"47","article-title":"Peripheral blood eosinophilia in atopic dermatitis","volume":"16","author":"Jenerowicz","year":"2007","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"B78","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1523-1747.ep12514346","article-title":"The structure of normal skin and the morphology of atopic eczema","volume":"67","author":"Mihm","year":"1976","journal-title":"J Invest Dermatol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1046\/j.1365-2133.2001.04456.x","article-title":"Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining","volume":"145","author":"Kiehl","year":"2001","journal-title":"Br J Dermatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/jid.2008.74","article-title":"Th2 cytokines act on S100\/A11 to downregulate keratinocyte differentiation","volume":"128","author":"Howell","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.4049\/jimmunol.171.6.3262","article-title":"Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes","volume":"171","author":"Nomura","year":"2003","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00403-004-0455-6","article-title":"Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis","volume":"295","author":"Tazawa","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.4049\/jimmunol.1002568","article-title":"Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways","volume":"186","author":"Choy","year":"2011","journal-title":"J Immunol"},{"key":"B86","first-page":"171","article-title":"IL-13 gene expression in patients with atopic dermatitis: relation to IgE level and to disease severity","volume":"11","author":"Metwally","year":"2004","journal-title":"Egypt J Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1398-9995.2005.00733.x","article-title":"CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children","volume":"60","author":"La Grutta","year":"2005","journal-title":"Allergy"},{"key":"B88","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11882-004-0071-8","article-title":"Keratinocytes in atopic dermatitis: inflammatory signals","volume":"4","author":"Esche","year":"2004","journal-title":"Curr Allergy Asthma Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/jid.2008.295","article-title":"Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling","volume":"129","author":"Zheng","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.4049\/jimmunol.0901860","article-title":"IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation","volume":"184","author":"Sehra","year":"2010","journal-title":"J Immunol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jgm.1268","article-title":"Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis","volume":"11","author":"Kim","year":"2009","journal-title":"J Gene Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jdermsci.2008.12.006","article-title":"Profiling the dysregulated genes of keratinocytes in atopic dermatitis patients: cDNA microarray and interactomic analyses","volume":"54","author":"L\u00fc","year":"2009","journal-title":"J Dermatol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1038\/sj.onc.1204629","article-title":"Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways","volume":"20","author":"David","year":"2001","journal-title":"Oncogene"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6802","DOI":"10.4049\/jimmunol.1002118","article-title":"IL-13R\u03b12 has a protective role in a mouse model of cutaneous inflammation","volume":"185","author":"Sivaprasad","year":"2010","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jaad.2016.04.054","article-title":"Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): a phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)","volume":"75","author":"Simpson","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"w13513","DOI":"10.4414\/smw.2012.13513","article-title":"Eosinophilic esophagitis: rapidly emerging disorder","volume":"142","author":"Straumann","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"B97","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.gtc.2014.02.002","article-title":"Epidemiology of eosinophilic esophagitis","volume":"43","author":"Dellon","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"B98","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.gtc.2014.02.007","article-title":"Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases","volume":"43","author":"Collins","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"B100","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/mi.2010.88","article-title":"Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease","volume":"4","author":"Mulder","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.4049\/jimmunol.0903069","article-title":"Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis","volume":"184","author":"Blanchard","year":"2010","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1172\/JCI26679","article-title":"Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis","volume":"116","author":"Blanchard","year":"2006","journal-title":"J Clin Invest"},{"key":"B103","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ng.547","article-title":"Common variants at 5q22 associate with pediatric eosinophilic esophagitis","volume":"42","author":"Rothenberg","year":"2010","journal-title":"Nat Genet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ng.3033","article-title":"Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease","volume":"46","author":"Kottyan","year":"2014","journal-title":"Nat Genet"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e86355","DOI":"10.1172\/jci.insight.86355","article-title":"Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment","volume":"1","author":"Davis","year":"2016","journal-title":"JCI Insight"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jaci.2012.06.044","article-title":"Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation","volume":"130","author":"Choy","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/modpathol.2013.41","article-title":"Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis","volume":"26","author":"Matoso","year":"2013","journal-title":"Mod Pathol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/gene.2014.27","article-title":"Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing","volume":"15","author":"Sherrill","year":"2014","journal-title":"Genes Immun"},{"key":"B109","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/mi.2014.109","article-title":"Neurotrophic tyrosine kinase receptor 1 is a direct transcriptional and epigenetic target of IL-13 involved in allergic inflammation","volume":"8","author":"Rochman","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","article-title":"Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis","volume":"135","author":"Rothenberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B111","first-page":"3, 1","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"key":"B112","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.jaci.2006.09.005","article-title":"Rhinosinusitis: developing guidance for clinical trials","volume":"118","author":"Meltzer","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B113","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2007","volume":"20","author":"Fokkens","year":"2007","journal-title":"Rhinol Suppl"},{"key":"B114","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1398-9995.2005.00688.x","article-title":"Prevalence of nasal polyposis in France: a cross-sectional, case-control study","volume":"60","author":"Klossek","year":"2005","journal-title":"Allergy"},{"key":"B115","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/000348940311200709","article-title":"Prevalence of nasal polyps in adults: the Sk\u00f6vde population-based study","volume":"112","author":"Johansson","year":"2003","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.2500\/ajra.2015.29.4131","article-title":"Prevalence of nasal polyps and its risk factors: Korean National Health and Nutrition Examination Survey 2009\u20132011","volume":"29","author":"We","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/alr.21298","article-title":"Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression","volume":"4","author":"Wise","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2500\/ajr.2008.22.3136","article-title":"Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells","volume":"22","author":"Ramanathan","year":"2008","journal-title":"Am J Rhinol"},{"key":"B120","first-page":"171","article-title":"Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression","volume":"35","author":"Bartels","year":"1997","journal-title":"Rhinology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1067\/mai.2001.112374","article-title":"Total and specific IgE in nasal polyps is related to local eosinophilic inflammation","volume":"107","author":"Bachert","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B122","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.163.3.1545","article-title":"Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia","volume":"163","author":"Jahnsen","year":"1999","journal-title":"J Immunol"},{"key":"B123","first-page":"235","article-title":"IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration","volume":"45","author":"Yoshifuku","year":"2007","journal-title":"Rhinology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"26604","DOI":"10.1038\/srep26604","article-title":"Transcriptome analysis reveals distinct gene expression profiles in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B125","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00139\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T01:46:45Z","timestamp":1693014405000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2017.00139\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":125,"alternative-id":["10.3389\/fmed.2017.00139"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2017.00139","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"article-number":"139"}}